// App-Quantinova.ai

4134 : Higher Infused Cell Dose Is Associated with a Decreased Risk of Invasive Fungal Infections After Allogeneic Hematopoietic Stem Cell Transplantation

Researchers

Presenter

  • Panayiotis D Ziakas

Principal Investigators

  • Theodora Anagnostou

  • Themistoklis Kourkoumpetis

  • Steven L. McAfee

  • Bimalangshu R. Dey

  • Eyal C. Attar

  • Yi-Bin A. Chen

  • Thomas R. Spitzer

  • Eleftherios E Mylonakis

  • Karen K. Ballen

Medical Centers

  • Department of Medicine/Leukemia and Bone Marrow Transplant, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA,

  • Department of Experimental Physiology, Medical School, University of Athens, Athens, Greece

Locations

  • United States

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Lymphocytic Leukemia

  • Invasive fungal infection

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Hematological malignancies

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Non‐Hodgkin Lymphoma

  • Diabetes

  • Lymphomas

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • Cluster of Differentiation 34

  • Hematocrit

Drug/Treatment

  • Fluconazole

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved